Tradestie Institutional Equity Comparison Engine
MXCT vs RCEL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RCEL Overall Edge
RCEL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus RCEL at 10.3x Forward P/E and -33.9% operating margin (+53.1% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
RCEL
MXCT N/M vs RCEL 10.3x Fwd P/E
Growth & Margin Winner
RCEL
Op Margin -85.5% vs -33.9% ยท YoY +48.7% vs +53.1%
Momentum & Technical Winner
RCEL
1Y -19.4% vs +295.4% ยท 52W Pos 63% vs 82%
Options & Structure Winner
RCEL
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
MXCT
NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap
$132.2M
1M Return
-4.2%
1Y Return
-19.41%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 46.0
Fund 52.0
Flow 62.0
Mom 50.0
RCEL
NASDAQ
Avita Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.62
-2.31% 1D
Market Cap
$506.7M
1M Return
+1.3%
1Y Return
+295.44%
Forward P/E
10.3x
Unified AI Score
45.6 / 100
HOLD
Tech 32.0
Fund 44.0
Flow 69.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MXCT -19.41%
RCEL +295.44%
Spread: +314.85 pp (RCEL Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MXCT Revenue | RCEL Revenue | MXCT Op. Margin | RCEL Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -1489.9% | RCEL |
| FY2019 | $10M | $10M | -93.7% | -466.4% | MXCT |
| FY2020 | $20M | $10M | -71.6% | -299.2% | MXCT |
| FY2021 | $20M | $30M | -84.3% | -90.8% | MXCT |
| FY2022 | $30M | $30M | -95.2% | -79.9% | RCEL |
| FY2023 | $20M | $50M | -247.7% | -85.1% | RCEL |
| FY2024 | $20M | $60M | -230.5% | -88.1% | RCEL |
| FY2025 | $20M | $70M | -247.6% | -59.4% | RCEL |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MXCT | RCEL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $506.7M | Larger Scale | RCEL |
| Trailing P/E Ratio Valuation | N/M | 10.3x | Lower Multiple | RCEL |
| Forward P/E Ratio Valuation | N/M | 10.3x | Lower Multiple | RCEL |
| Revenue Growth (YoY) Growth | +48.7% | +53.1% | Higher Growth | RCEL |
| Operating Margin (TTM) Profitability | -85.5% | -33.9% | Higher Margin | RCEL |
| Net Profit Margin Profitability | -81.4% | -42.6% | Higher Margin | RCEL |
| Return on Equity (ROE) Capital Efficiency | -16.9% | -1746.3% | Higher ROE | MXCT |
| 52-Week Range Position Momentum | 63% ($1โ$2) | 82% ($3โ$18) | Stronger Trend | RCEL |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 96% Vol | 1.54ฮฒ ยท 65% Vol | Lower Realized Risk | RCEL |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 45.6 / 100 (HOLD) | Higher Composite | RCEL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MXCT vs RCEL Buy Guide
MXCT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
RCEL
CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MXCT nor RCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.